EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney Disease

Emmanuel Lafont iD, Damien Blez, Marc-Antoine Bildan, David Veyer, Hélène Péré, Julien Puech, Benjamin Kably, Geoffrey Cheminet, Jacques Pouchot, Eric Thervet, Gilles Peytavin iD, Helene Lazareth

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad785 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Emmanuel Lafont und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Ritonavir, COVID-19 Drug Treatment, Renal Insufficiency, Chronic, Drug Therapy, Combination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitonavirCOVID-19 Drug TreatmentRenal Insufficiency, ChronicDrug Therapy, CombinationHumansMaleAgedFemaleSARS-CoV-2Middle AgedAntiviral AgentsCOVID-19

Substanzen

RitonavirAntiviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Bacteriology Laboratory, Microbiology Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Pharmacology Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Virology Laboratory, Microbiology Department, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Unité mixte de recherche 1137, Infections Antimicrobials Modelling Evolution, Université Paris Cité, Paris, France.
  • Université Paris Cité, Paris, France.

ORCID-Profile: Emmanuel Lafont, Gilles Peytavin

Zitieren

APA

Lafont, E., Blez, D., Bildan, M. A., Veyer, D., Péré, H., Puech, J., Kably, B., Cheminet, G., Pouchot, J., Thervet, E., Peytavin, G., & Lazareth, H. (2024). Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney Disease. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad785

Vancouver

Lafont E, Blez D, Bildan MA, Veyer D, Péré H, Puech J, et al. Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney Disease. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad785

BibTeX
@article{Lafont2024,
  author = {Lafont, Emmanuel and Blez, Damien and Bildan, Marc-Antoine and Veyer, David and Péré, Hélène and Puech, Julien and Kably, Benjamin and Cheminet, Geoffrey and Pouchot, Jacques and Thervet, Eric and Peytavin, Gilles and Lazareth, Helene},
  title = {Nirmatrelvir and Ritonavir Combination in COVID-19 Patients With Advanced Chronic Kidney Disease},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad785}
}
Kostenlos starten →